CONTOUR^® NEXT LINK 2.4

The CONTOUR^®NEXT LINK 2.4 is the only blood glucose meter that integrates seamlessly with your MiniMed™ 640G or 670G insulin pump system. It has demonstrated high accuracy¹ to help you get the most out of your insulin pump and Continuous Glucose Monitoring (CGM) therapy.

• Wireless communication: Blood glucose results are sent automatically from the meter to your pump. This removes the risk of manual entry errors and helps you save time during CGM calibration and insulin dosing
• Precise CGM calibration: A highly accurate meter is essential for CGM system calibration and reliable performance. Using the CONTOUR^®NEXT LINK 2.4 meter for CGM calibration will help you make reliable therapy decisions²
• Better control: The CONTOUR^®NEXT LINK 2.4 meter helps you make accurate insulin dosing decisions, reducing the risk of hypoglycaemia and hyperglycaemia^3,4
• Remote bolus: Use your CONTOUR^®NEXT LINK 2.4 to send a manual or preset bolus directly to your pump, for convenience and discretion*
• USB connectivity: Use your CONTOUR^®NEXT LINK 2.4 to send blood glucose and insulin data to Medtronic’s CareLink™ Personal Software or use it to recharge the battery

"I use the CONTOUR^®NEXT LINK 2.4 meter with my pump and CGM because it makes me feel safe”

MiniMed™ 670G system user

How to obtain a CONTOUR^®NEXT LINK 2.4 meter?

If you use a Medtronic MiniMed™ 640G or 670G insulin pump, a CONTOUR^®NEXT LINK 2.4 blood glucose meter will be delivered automatically to you with your pump.

For further information on how your meter can help optimise your therapy with your MiniMed™ insulin pump system, or to obtain a second CONTOUR^®NEXT LINK 2.4 meter, please contact our Ascensia Diabetes Care Service:

| 0123 – 45 67 891 011 | info@ascensia.com

For further information on the MiniMed™ 640G and 670G insulin pump systems, please contact Medtronic:

| 0123 – 45 67 891 011 | info@ascensia.com

* Der Fern-Bolus ist verfügbar, sofern das MiniMed™ 670G System nicht im Auto-Modus betrieben wird.

Referenzen:

1. Bailey T et al. Accuracy and User Performance Evaluation of the CONTOUR^® NEXT LINK 2.4 blood glucose monitoring system. Clinica Chimica Acta 2015; 448:139 -145.
2. Heinemann L. Continuous Glucose Monitoring (CGM) or Blood Glucose Monitoring (BGM): Interactions and Implications. J Diabetes Sci Technol 2018;12:873-879.
3. Budiman ES et al. Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems. J Diabetes Sci Technol 2013; 7:265–380.
4. Walsh J. et al. New Criteria for Assessing the Accuracy of Blood Glucose Monitors Meeting, October 28, 2011. J Diabetes Sci Technol 2012; 6(2):466–47
5. Danne T. et al. Diabetes Care 2017; 40:1631-1640.
6. Heinemann L. et al. Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future? European Endocrinology, 2018;14(2):24-9.
7. Freckmann G. et al. 898-P: Accuracy evaluation of six blood glucose monitoring systems often used with insulin pumps following ISO 15197, Abschnitt 6.3. Poster presented at ADA 2016, New Orleans, USA.
8. Budiman ES et al. Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems. J Diabetes Sci Technol 2013;7(2):365–380.

Why does accuracy matter?

The accuracy of a blood glucose monitoring system is an essential part of any pump or CGM system as it has a major impact on the quality of the calibration and the performance of these systems.⁵

In a laboratory study, the CONTOUR^®NEXT LINK 2.4 meter has been demonstrated as highly accurate with 99% of results within ± 10% of lab reference values (YSI reference)⁶ helping you to optimise your insulin pump therapy.

• Highly accurate blood glucose readings can help you adjust your insulin bolus dose more confidently⁷
• MultiPulse technology ensures accurate glucose measurements, even when blood glucose levels are low
• Accuracy is not affected by common interfering substances

For further information on the MiniMed™ 640G and 670G insulin pump systems, please visit www.medtronic-diabetes.xx/local-subpage.

* Der Fern-Bolus ist verfügbar, sofern das MiniMed™ 670G System nicht im Auto-Modus betrieben wird.

Referenzen:

1. Bailey T et al. Accuracy and User Performance Evaluation of the CONTOUR^® NEXT LINK 2.4 blood glucose monitoring system. Clinica Chimica Acta 2015; 448:139 -145.
2. Heinemann L. Continuous Glucose Monitoring (CGM) or Blood Glucose Monitoring (BGM): Interactions and Implications. J Diabetes Sci Technol 2018;12:873-879.
3. Budiman ES et al. Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems. J Diabetes Sci Technol 2013; 7:265–380.
4. Walsh J. et al. New Criteria for Assessing the Accuracy of Blood Glucose Monitors Meeting, October 28, 2011. J Diabetes Sci Technol 2012; 6(2):466–47
5. Danne T. et al. Diabetes Care 2017; 40:1631-1640.
6. Heinemann L. et al. Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future? European Endocrinology, 2018;14(2):24-9.
7. Freckmann G. et al. 898-P: Accuracy evaluation of six blood glucose monitoring systems often used with insulin pumps following ISO 15197, Abschnitt 6.3. Poster presented at ADA 2016, New Orleans, USA.
8. Budiman ES et al. Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems. J Diabetes Sci Technol 2013;7(2):365–380.

Additional benefits

• Easy sampling: 5-second countdown with small sample size of 0.6 µL, Second-Chance^® sampling lets you apply more blood if needed, helping to prevent lancing a second time and wasting strips
• Personalised settings: You can set test reminders, customise target values, add meal markers and read out trends from a memory of 1000 tests
• And some more: Rechargeable battery via USB port, illuminated strip port and display for testing in the dark, 14 different language options